Angiomax in patients with HIT/HITTS type II undergoing off-pump CABG.
Phase of Trial: Phase III
Latest Information Update: 04 Dec 2018
At a glance
- Drugs Bivalirudin (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms CHOOSE
- Sponsors The Medicines Company
- 29 Nov 2018 Status changed from active, no longer recruiting to completed.
- 09 Nov 2011 Planned end date added as 1 Sep 2005 as reported by ClinicalTrials.gov.
- 30 Oct 2005 New trial record.